Heat shock proteins 90-alpha (HSP90α) antibody and antigen (Recombinant protein)

Diagnostic Heat shock proteins 90-alpha (HSP90α) antibodies (anti-Heat shock proteins 90-alpha (HSP90α), anti-HSP90α) and antigens (recombinant Heat shock proteins 90-alpha (HSP90α) protein) for Cancer HSP90α detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-h-HSP90-Ag01 Recombinant human HSP90AA1/HSP90α/HSP90A/HSPC1 Protein 3090
GMP-h-HSP90-Ab01 Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 mouse monoclonal antibody (mAb) 1953
GMP-h-HSP90-Ab02 Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 mouse monoclonal antibody (mAb) 1953
GMP-h-HSP90-Ab03 Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 human monoclonal antibody (mAb) 1953
GMP-h-HSP90-Ab04 Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-h-HSP90-Ag01
Product Name Recombinant human HSP90AA1/HSP90α/HSP90A/HSPC1 Protein
Target/Biomarker Heat shock proteins 90-alpha (HSP90α) (HSP90α)
Alias of Target/Biomarker EL52, HEL-S-65p, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp103, Hsp89, Hsp90, LAP-2, LAP2
Expression platform mammalian
Isotypes Recombinant Antigen
Bioactivity validation Heat shock proteins 90-alpha (HSP90α) (HSP90α) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HSP90α level test of Cancer (renal cancer, liver cancer and breast cancer) and related syndrome evaluation.
Tag His
Products description Recombinant human HSP90AA1/HSP90α/HSP90A/HSPC1 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-h-HSP90-Ab01, GMP-h-HSP90-Ab02
Product Name Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 mouse monoclonal antibody (mAb)
Target/Biomarker Heat shock proteins 90-alpha (HSP90α) (HSP90α)
Alias of Target/Biomarker EL52, HEL-S-65p, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp103, Hsp89, Hsp90, LAP-2, LAP2
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Heat shock proteins 90-alpha (HSP90α) (HSP90α) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HSP90α level test of Cancer (renal cancer, liver cancer and breast cancer) and related syndrome evaluation.
Tag mFc
Products description Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-h-HSP90-Ab03, GMP-h-HSP90-Ab04
Product Name Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 human monoclonal antibody (mAb)
Target/Biomarker Heat shock proteins 90-alpha (HSP90α) (HSP90α)
Alias of Target/Biomarker EL52, HEL-S-65p, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp103, Hsp89, Hsp90, LAP-2, LAP2
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Heat shock proteins 90-alpha (HSP90α) (HSP90α) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HSP90α level test of Cancer (renal cancer, liver cancer and breast cancer) and related syndrome evaluation.
Tag hFc
Products description Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    The Hsp90 family of heat shock proteins represents one of the most abundantly expressed and highly conserved families of cellular chaperones whose expression can be upregulated under conditions of cellular stress, and includes cytoplasmic (Hsp90-alpha/beta), ER (grp94), and mitochondrial (TRAP1) localized members. Structurally, Hsp90 is characterized by an N-terminal ATP-binding domain, a medial substrate-binding domain, and a C-terminal dimerization motif. Hsp90 dimers function in cooperation with cochaperones (e.g. Hsp40, Hsp70, Hop, p23) to stabilize a multitude of client protein substrates, including steroid hormone receptors, protein kinases, and transcription factors. The essential binding and hydrolysis of ATP by Hsp90 is inhibited by ansamycin drugs (e.g. geldanamycin, 17-AAG) which occupy the N-terminal Hsp90 nucleotide-binding pocket. Many Hsp90 client proteins such as erbB2/Her-2, c-raf, bcr-abl, p53, and hTERT, are members of well characterized oncogenic pathways, making Hsp90 inhibitors useful anticancer agents.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment